Filing Details
- Accession Number:
- 0001209191-21-028984
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-04-29 16:03:30
- Reporting Period:
- 2021-04-27
- Accepted Time:
- 2021-04-29 16:03:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1406338 | Amit Sachdev | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Evp, Chief Patient Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-04-27 | 3,884 | $86.52 | 44,017 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-04-27 | 2,346 | $215.58 | 41,671 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-04-27 | 1,338 | $216.67 | 40,333 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-04-27 | 200 | $217.69 | 40,133 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2021-04-27 | 3,884 | $0.00 | 3,884 | $86.52 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2027-02-02 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 882 | Indirect | 401(k) |
| Common Stock | 7,368 | Indirect | Held in Trust |
Footnotes
- Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $215.58 (range $215.09 to $216.07).
- Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $216.67 (range $216.19 to $217.18).
- Open market sales reported on this line occurred at a weighted average price of $217.69 (range $217.60 to $217.78).
- Fully vested.
Billionaire Hedge Funds
